BioCryst Pharma News, BioCryst Pharma Quote, BCRX Quote

BioCryst Pharma (NQ:BCRX) Delayed: 9.51 +0.09 (0.96%)

Prev. Close

$9.42

Today 6M 1Y 5Y

Open

$9.37

52 Wk High

$10.98

52 Wk Low

$1.63

Day High

$9.69

Day Low

$9.36

P/E

N/A

EPS

$-0.68

Volume

2,550,094

Friends, Peers and Foes (?): ATXS, ACAD, DYN, XENE, CDTX (more...)

ALERTS | RSS

Jul 22, 2026 07:00 AM BioCryst to Report Second Quarter 2026 Financial Results on August 5
Jul 17, 2026 05:10 AM BioCryst Pharma (BCRX) Reiterated at Market Outperform by Citizens on Orladeyo Potential
Jul 15, 2026 07:01 AM BioCryst names David Jenkins as chief scientific officer
Jul 15, 2026 07:00 AM BioCryst Appoints David W. Jenkins as Chief Scientific Officer
Jul 13, 2026 03:15 AM JPMorgan Resumes BioCryst Pharma (BCRX) at Neutral
Jul 7, 2026 07:55 AM BioCryst Pharma (BCRX) PT Raised to $14 at RBC Capital
Jul 2, 2026 07:00 AM BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 30, 2026 04:42 AM BioCryst Pharma (BCRX) PT Raised to $17 at Jefferies
Jun 29, 2026 07:07 AM Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 25
Jun 29, 2026 07:00 AM BioCryst to close Birmingham lab and shift to external R&D model

Entities mentioned with BCRX

View All Entities